These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27536979)
21. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study. Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729 [TBL] [Abstract][Full Text] [Related]
22. Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries. Burgos-Soto J; Balestre E; Minga A; Ajayi S; Sawadogo A; Zannou MD; Leroy V; Ekouevi DK; Dabis F; Becquet R; J Acquir Immune Defic Syndr; 2014 Oct; 67(2):e45-54. PubMed ID: 25216079 [TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. Nglazi MD; Kranzer K; Holele P; Kaplan R; Mark D; Jaspan H; Lawn SD; Wood R; Bekker LG BMC Infect Dis; 2012 Jan; 12():21. PubMed ID: 22273267 [TBL] [Abstract][Full Text] [Related]
24. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015). Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432 [TBL] [Abstract][Full Text] [Related]
25. Retention in Care among HIV-Infected Adults in Ethiopia, 2005- 2011: A Mixed-Methods Study. Tiruneh YM; Galárraga O; Genberg B; Wilson IB PLoS One; 2016; 11(6):e0156619. PubMed ID: 27272890 [TBL] [Abstract][Full Text] [Related]
26. Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care? Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S PLoS One; 2020; 15(9):e0238687. PubMed ID: 32911516 [TBL] [Abstract][Full Text] [Related]
27. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya. Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350 [TBL] [Abstract][Full Text] [Related]
28. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa. Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S; HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667 [TBL] [Abstract][Full Text] [Related]
29. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India. Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312 [TBL] [Abstract][Full Text] [Related]
30. Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men. Aliyu MH; Blevins M; Megazzini KM; Parrish DD; Audet CM; Chan N; Odoh C; Gebi UI; Muhammad MY; Shepherd BE; Wester CW; Vermund SH Int Health; 2015 Nov; 7(6):405-11. PubMed ID: 26012740 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012. Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033 [TBL] [Abstract][Full Text] [Related]
32. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. Patterson S; Cescon A; Samji H; Chan K; Zhang W; Raboud J; Burchell AN; Cooper C; Klein MB; Rourke SB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; BMC Infect Dis; 2015 Jul; 15():274. PubMed ID: 26183704 [TBL] [Abstract][Full Text] [Related]
33. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L; PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181 [TBL] [Abstract][Full Text] [Related]
34. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA; J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185 [TBL] [Abstract][Full Text] [Related]
35. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Alvarez-Uria G; Naik PK; Pakam R; Midde M Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937 [TBL] [Abstract][Full Text] [Related]
36. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. ; Slogrove AL; Schomaker M; Davies MA; Williams P; Balkan S; Ben-Farhat J; Calles N; Chokephaibulkit K; Duff C; Eboua TF; Kekitiinwa-Rukyalekere A; Maxwell N; Pinto J; Seage G; Teasdale CA; Wanless S; Warszawski J; Wools-Kaloustian K; Yotebieng M; Timmerman V; Collins IJ; Goodall R; Smith C; Patel K; Paul M; Gibb D; Vreeman R; Abrams EJ; Hazra R; Van Dyke R; Bekker LG; Mofenson L; Vicari M; Essajee S; Penazzato M; Anabwani G; Q Mohapi E; N Kazembe P; Hlatshwayo M; Lumumba M; Goetghebuer T; Thorne C; Galli L; van Rossum A; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaia L; Rojo P; Fortuny C; Naver L; Rudin C; Le Coeur S; Volokha A; Rouzier V; Succi R; Sohn A; Kariminia A; Edmonds A; Lelo P; Ayaya S; Ongwen P; Jefferys LF; Phiri S; Mubiana-Mbewe M; Sawry S; Renner L; Sylla M; Abzug MJ; Levin M; Oleske J; Chernoff M; Traite S; Purswani M; Chadwick EG; Judd A; Leroy V PLoS Med; 2018 Mar; 15(3):e1002514. PubMed ID: 29494593 [TBL] [Abstract][Full Text] [Related]
37. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic. Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P Glob Health Action; 2016; 9():29943. PubMed ID: 26765104 [TBL] [Abstract][Full Text] [Related]
38. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML; Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055 [TBL] [Abstract][Full Text] [Related]
39. Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data. Lilian RR; Rees K; McIntyre JA; Struthers HE; Peters RPH PLoS One; 2020; 15(1):e0227572. PubMed ID: 31935240 [TBL] [Abstract][Full Text] [Related]
40. Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa. Leroi C; Balestre E; Messou E; Minga A; Sawadogo A; Drabo J; Maiga M; Zannou M; Seydi M; Dabis F; Jaquet A; PLoS One; 2017; 12(1):e0170753. PubMed ID: 28122041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]